This Article Full Text Full Text (PDF) All Versions of this Article: 147/11/5284    most recent Author Manuscript (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tomlinson, J. J. Articles by Haché, R. J. G. Search for Related Content PubMed PubMed Citation Articles by Tomlinson, J. J. Articles by Haché, R. J. G. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB DEXAMETHASONE Medline Plus Health Information Stem Cells

Modulation of Early Human Preadipocyte Differentiation by Glucocorticoids

The Ottawa Health Research Institute (A.B., D.W., E.A., R.J.G.H.) and the Departments of Medicine (R.J.G.H.) and Biochemistry, Microbiology, and Immunology (J.J.T.), University of Ottawa, Ottawa, Ontario, Canada K1Y 4E9

Address all correspondence and requests for reprints to: Robert J. G. Haché, Ottawa Health Research Institute, 725 Parkdale Avenue, Ottawa, Ontario, Canada K1Y 4E9. E-mail: rhache{at}ohri.ca.

Glucocorticoids provide an adipogenic stimulus that is most obvious in the truncal obesity of patients with Cushing’s syndrome. Glucocorticoid treatment also strongly potentiates the differentiation of human preadipocytes in culture. However, the molecular basis of these stimulatory effects remains to be defined. In this study, we provide a detailed analysis of the specific contribution of glucocorticoid treatment to the differentiation of primary human preadipocytes cultured in chemically defined medium. Contrary to previous descriptions of glucocorticoids being required throughout the course of differentiation, our results show that glucocorticoid treatment is stimulatory only during the first 48 h of differentiation. Furthermore, stimulation by glucocorticoids and the peroxisome proliferator activator receptor- agonist troglitazone is mediated sequentially. Several details of the early events in the differentiation of human preadipocytes and the contribution of steroid to these events differ from the responses observed previously in murine preadipocyte models. First, glucocorticoid treatment stimulated the early accumulation of CCAAT enhancer binding protein-ß (C/EBPß) in primary human preadipocytes. Second, induction of C/EBP in primary human preadipocytes was noted within 4 h of adipogenic stimulus, whereas C/EBP induction is not detected until 24–48 h in the murine 3T3 L1 preadipocyte model. Remarkably, by contrast to human primary preadipocytes, which do not undergo postconfluent mitosis, 3T3 L1 murine preadipocytes stimulated to differentiate under chemically defined conditions required glucocorticoids to survive the clonal expansion that precedes terminal differentiation, revealing a novel signal imparted by glucocorticoids in this immortalized murine cell system.

This article has been cited by other articles:

				G. J. Hausman, S. P. Poulos, T. D. Pringle, and M. J. Azain The influence of thiazolidinediones on adipogenesis in vitro and in vivo: Potential modifiers of intramuscular adipose tissue deposition in meat animals J Anim Sci, April 1, 2008; 86(14_suppl): E236 - E243. [Abstract] [Full Text] [PDF]

				C. E. Perrone, D. A. L. Mattocks, G. Hristopoulos, J. D. Plummer, R. A. Krajcik, and N. Orentreich Methionine restriction effects on 11 -HSD1 activity and lipogenic/lipolytic balance in F344 rat adipose tissue J. Lipid Res., January 1, 2008; 49(1): 12 - 23. [Abstract] [Full Text] [PDF]